P
Paul Monagle
Researcher at Royal Children's Hospital
Publications - 395
Citations - 14736
Paul Monagle is an academic researcher from Royal Children's Hospital. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 53, co-authored 363 publications receiving 12579 citations. Previous affiliations of Paul Monagle include Monash Medical Centre & Hamilton Health Sciences.
Papers
More filters
Journal ArticleDOI
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Paul Monagle,Anthony K.C. Chan,Neil A. Goldenberg,Rebecca Ichord,Janna M. Journeycake,Ulrike Nowak-Göttl,Sara K. Vesely +6 more
TL;DR: The evidence supporting most recommendations for antithrombotic therapy in neonates and children remains weak and Studies addressing appropriate drug target ranges and monitoring requirements are urgently required in addition to site- and clinical situation-specific thrombosis management strategies.
Journal ArticleDOI
Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Paul Monagle,Elizabeth Chalmers,Anthony K.C. Chan,Gabrielle deVeber,Fenella J. Kirkham,Patricia Massicotte,Alan D. Michelson +6 more
TL;DR: Within this chapter, the majority of recommendations are separate for neonates and children, reflecting the significant differences in epidemiology of thrombosis and safety and efficacy of therapy in these two populations.
Journal ArticleDOI
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry.
Paul Monagle,Margaret Adams,M Mahoney,K Ali,Dorothy R. Barnard,M Bernstein,L Brisson,M. David,Shalini Desai,M F Scully,Jacqueline Halton,Sara J. Israels,Lawrence Jardine,Michael Leaker,Patricia McCusker,M. Silva,Jianhong Wu,Ross Anderson,Maureen Andrew,M.P. Massicotte +19 more
TL;DR: The significant mortality and morbidity found in this study supports the need for international multicenter randomized clinical trials to determine optimal prophylactic and therapeutic treatment for children with DVT/PE.
Journal ArticleDOI
Developmental haemostasis : Impact for clinical haemostasis laboratories
Paul Monagle,Chris Barnes,Vera Ignjatovic,Janine Furmedge,Fiona Newall,Anthony K.C. Chan,Lidia De Rosa,Simone Hamilton,Philip Ragg,Stephen Robinson,Alex Auldist,Catherine Crock,Neil Roy,Shelley Rowlands +13 more
TL;DR: The results confirm the need for coagulation laboratories to develop age-related reference ranges specific to their own testing systems and confirm that accurate diagnosis and management of neonates and children with suspected bleeding or clotting disorders is not possible.
Journal ArticleDOI
Antithrombotic Therapy in Children
TL;DR: The following review summarizes the available information on commonly used antithrombotic agents in children, which include standard heparin, low molecular hepar in, oral anticoagulants, thrombolytic therapy, antiplatelet agents, antithromabin concentrates, and protein C concentrates.